c-MYC partners with BPTF in human cancer

Molecular and Cellular Oncology

Volumn 3, Issue 3, 2016, Pages

  Richart, Laia ^a   Real, Francisco X ^a,b   Sanchez Arevalo Lobo, Victor Javier ^a  

^a Centro Nacional de Investigaciones Oncológicas   (Spain)

^b UNIVERSITAT POMPEU FABRA   (Spain)

Author keywords

BPTF; c MYC; chromatin remodeling; transcription

Indexed keywords

EID: 85026807486     PISSN: None     EISSN: 23723556     Source Type: Journal    
DOI: 10.1080/23723556.2016.1152346     Document Type: Article

References (10)

1. Alkhatib SG, Landry JW. The nucleosome remodeling factor. FEBS lett 2011; 585:3197-207; PMID:21920360; http://dx.doi.org/10.1016/j.febslet.2011.09.003
2. Blackwell TK, Huang J, Ma A, Kretzner L, Alt FW, Eisenman RN, Weintraub H. Binding of Myc proteins to canonical and noncanonical DNA sequences. Mol Cell Biol 1993; 13:5216-24; PMID:8395000; http://dx.doi.org/10.1128/MCB.13.9.5216
3. Dawson M, Prinjha R, Dittmann A, Giotopoulos G, Bantscheff M, Chan WI, Robson SC, Chung CW, Hopf C, Savitski MM, et al. Inhibition of BET recruitment to chromatin as an effective treatment for MLL-fusion leukaemia. Nature 2011; 478:529-33; PMID:21964340; http://dx.doi.org/10.1038/nature10509
4. Guccione E, Martinato F, Finocchiaro G, Luzi L, Tizzoni L, Dall' Olio V, Zardo G, Nervi C, Bernard L, Amati B. Myc binding-site recognition in the human genome is determined by chromatin context. Nat Cell Biol 2006; 8:764-70; PMID:16767079; http://dx.doi.org/10.1038/ncb1434
5. Hoffman B, Liebermann DA. Apoptotic signaling by c-MYC. Oncogene 2008; 27:6462-72; PMID: 18955973; http://dx.doi.org/10.1038/onc.2008.312
6. Perna D, Fagà G, Verrecchia A, Gorski MM, Barozzi I, Narang V, Khng J, Lim KC, Sung WK, Sanges R, et al. Genome-wide mapping of Myc binding and gene regulation in serum-stimulated fibroblast. Oncogene 2012; 31:1695-1709; PMID: 21860422; http://dx.doi.org/10.1038/onc.2011.359
7. Sabò A, Amati B. Genome recognition by MYC. Cold Spring Harb Perspect Med 2014; 4:pii: a014191; PMID: 24492846; http://dx.doi.org/10.1101/cshperspect.a014191
8. Soucek L, Whitfield J, Martins CP, Finch AJ, Murphy DJ, Sodir NM, Karnezis AN, Swigart LB, Nasi S, Evan GI. Modelling Myc inhibition as a cancer therapy. Nature 2008; 455:679-83; PMID: 18716624; http://dx.doi.org/10.1038/nature07260
9. Thomas L, Wang Q, Grieb B, Phan J. Interaction with WDR5 Promotes Target Gene Recognition and Tumorigenesis by MYC. Mol Cell 2015; 58:440-52; PMID: 25818646; http://dx.doi.org/10.1016/j.molcel.2015.02.028
10. Adhikary S, Eilers M. Transcriptional regulation and transformation by Myc proteins. Nat Rev Mol Cell Biol 2005; 6:635-45; PMID: 16064138; http://dx.doi.org/10.1038/nrm1703